EBR and Research Value
Making EBR possible, easier, and the norm: funders’ and researchers’ roles
Paul Glasziou | Professor of Evidence-Based Medicine at Bond University. Co-founder of the International Collaboration for the Automation of Systematic Reviews (ICASR).
EBR and Research Value
Quality of clinical trials and its relation with research integrity
Joeri Tijdink | Assistant Professor in the Philosophy Department (Faculty of Humanities) and Prinicipal Investigator at the Ethics, Law and Humanities department of the Amsterdam UMC.
Answering the four statements on expectations of editors
James Barker | Associate Publisher at F1000, involved in implementing Living Evidence across the platforms with a particular focus on Living Systematic Reviews.
Are systematic reviews contributing to research waste?
Has registration succeeded in minimizing redundancy in systematic reviews?
Lesley Stewart | Head of Department and Director of the Centre for Reviews and Dissemination (CRD) at the University of York
Are systematic reviews contributing to research waste?
How to avoid redundancy in systematic reviews?
Livia Puljak | Professor at the Catholic University of Croatia and Head of its Center for Evidence-Based Medicine and Health Care.
When enough is enough? How to decide when we do not need more research
A case on exercise for patients with knee osteoarthritis
When enough is enough? How to decide when we do not need more research
Using a Bayesian approach to decide on the conclusiveness of systematic reviews
Jong Wook Ban | General Internist in Washington state, USA and Postdoctoral Research Fellow at the Western Norway University of Applied Sciences in Bergen, Norway.
Introducing the Global Commission on Evidence
Jeremy Grimshaw | Senior Scientist at the Ottawa Hospital Research Institute & Professor in the Department of Medicine, University of Ottawa, Canada.
Looking back to move EBR forward
What has changed since the paper from 1996: Are research ethics committees behaving unethically?
Julian Savulescu | Chen Su Lan Professor in Medical Ethics and director of the Centre for Biomedial Ethics at the National University of Singapore.
Looking back to move EBR forward
The present and the future of EBR in the light of the 1998 paper
Mike Clarke | Director of the Northern Ireland Methodology Hub, Director of the Northern Ireland Clinical Trials Unit and Co-ordinating Editor of the Cochrane Methodology Review Group
